Oncotelic Therapeutics Inc
OTC:OTLC
Oncotelic Therapeutics Inc
Income to Minority Interest
Oncotelic Therapeutics Inc
Income to Minority Interest Peer Comparison
Competitive Income to Minority Interest Analysis
Latest Figures & CAGR of Competitors
Company | Income to Minority Interest | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Oncotelic Therapeutics Inc
OTC:OTLC
|
Income to Minority Interest
$303k
|
CAGR 3-Years
-14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Income to Minority Interest
-$10m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Income to Minority Interest
$26m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
54%
|
CAGR 10-Years
4%
|
|
Amgen Inc
NASDAQ:AMGN
|
Income to Minority Interest
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Income to Minority Interest
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Income to Minority Interest
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Oncotelic Therapeutics Inc's Income to Minority Interest?
Income to Minority Interest
303k
USD
Based on the financial report for Dec 31, 2023, Oncotelic Therapeutics Inc's Income to Minority Interest amounts to 303k USD.
What is Oncotelic Therapeutics Inc's Income to Minority Interest growth rate?
Income to Minority Interest CAGR 3Y
-14%
Over the last year, the Income to Minority Interest growth was -28%. The average annual Income to Minority Interest growth rates for Oncotelic Therapeutics Inc have been -14% over the past three years .